Optimizing the dose of intrathecal morphine in patients undergoing laparoscopic donor hepatectomy; a randomized non-inferiority trial
Not Applicable
Completed
- Conditions
- Factors influencing health status and contact with health services
- Registration Number
- KCT0006526
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Patients who undergo living donor hepatectomy for liver transplantation
ASA physical status I or II
Exclusion Criteria
ASA physical status III or more
Severe impaired coagulation profile (equal or more than INR 1.5 last coagulation test before the surgery)
Patients who have unstable coronary disease or Congestive heart failure or Arrhythmia or cardiomyopathy
Patients who have cerebrovascular disease
Patients who have systemic infection or local infection on lumbar
Chronic pain patients
Patients who don't understand about study or refuse the study
Patients who have history of severe psychological disease
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain score (representing by 11-points Numerous Rating Scale)
- Secondary Outcome Measures
Name Time Method Pain score (representing by 11-points Numerous Rating Scale);Opioid consumption;Nausea, Vomiting, Pruritus;Pain relief satisfaction;Sleep satisfaction;First gas-out time;Hypoventilation, Hypotension, Headache;The questionaire of QoR-15 score before and after the surgery